The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Atkinson Edward Morrow Iii since 2023.
This trader's CIK number is 1914164.
At the time of last reporting, Atkinson Edward Morrow Iii was the EVP, Chief Technical Ops. Off. of Vertex Pharmaceuticals Inc / Ma. (stock ticker symbol VRTX).
Also see all insider trading activities at Vertex Pharmaceuticals Inc / Ma.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | ETNB | 0 | $0 | 16,250 | $247,937 | 16,250 | $60,712 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | VRTX | 0 | $0 | 6,164 | $2,912,812 | 0 | $0 |
| 2024 | VRTX | 0 | $0 | 10,285 | $4,749,781 | 0 | $0 |
2. Vertex Pharmaceuticals Inc / Ma (VRTX)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-06-01 | ETNB | Option Ex | 6,250 | 2.61 | 16,312 |
| 2023-06-01 | ETNB | Sale | 6,250 | 17.91 | 111,937 |
| 2023-03-01 | ETNB | Option Ex | 10,000 | 4.44 | 44,400 |
| 2023-03-01 | ETNB | Sale | 10,000 | 13.60 | 136,000 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-02-27 | VRTX | Sale | 2,650 | 475.34 | 1,259,651 |
| 2025-02-25 | VRTX | Sale | 1,767 | 480.95 | 849,838 |
| 2025-02-11 | VRTX | Sale | 1,747 | 459.83 | 803,323 |
| 2024-06-12 | VRTX | Sale | 7,288 | 478.00 | 3,483,664 |
| 2024-02-26 | VRTX | Sale | 883 | 425.70 | 375,893 |
| 2024-02-21 | VRTX | Sale | 1,201 | 421.77 | 506,545 |
| 2024-02-12 | VRTX | Sale | 913 | 420.24 | 383,679 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Atkinson Edward Morrow Iii (EVP, Chief Technical Ops. Off. of Vertex Pharmaceuticals Inc / Ma at the time of this reporting) see the Securities and Exchange Commission (SEC) website.